Bexson Biomedical

Neurocentrx Pharma Ltd

This biopharmaceutical company develops oral ketamine formulations to treat patients suffering from treatment-resistant mood disorders, neurodegenerative diseases, and complex pain conditions.

Freedom Biosciences

The company develops ketamine and psychedelic therapeutics for patients suffering from treatment-resistant depression and other mental health conditions.

Journey Clinical

This company provides a platform and medical infrastructure enabling psychotherapists to deliver ketamine-assisted psychotherapy to patients with mental health conditions.

Enabling psychedelics-assisted therapies

This biopharmaceutical company develops psychedelic-inspired medicines and a care delivery model to treat addiction for patients and healthcare providers.

Reunion Neuroscience

This biopharmaceutical company develops psychedelic-inspired therapeutic solutions for patients with underserved mental health disorders, such as postpartum depression and anxiety.

Sooma Medical

This company develops portable brain stimulation devices and digital platforms for clinicians to treat patients with depression and chronic pain.

Beckley Psytech

The company develops psychedelic-derived medicines to treat patients with neurological and psychiatric conditions such as treatment-resistant depression and rare headache disorders.

Mycrodose Therapeutics

This pharmaceutical company develops advanced drug delivery systems for psychedelic and cannabinoid compounds to treat mental health and cognitive degenerative diseases.